XOMA announced Natasha A. Hernday, Senior Vice President, Corporate Development at Seattle Genetics Inc., has joined the Company's Board of Directors. Ms. Hernday has 20 years of experience in corporate development and corporate strategy work and an extensive record of asset licensing, partnerships, and acquisition transactions. Prior to joining Seattle Genetics, she spent 16 years at Amgen, initially in research, then transitioning into project management and ultimately corporate development. Ms. Hernday has served on the Board at PDL BioPharma Inc., since June 2019.